Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy

Discover the cutting-edge advancements in cancer treatment with Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy by Shabir Ahmad Ganai. Published by Springer Verlag in 2021, this insightful paperback spans 258 pages and delves into the design, synthesis, and molecular mechanisms of Histone Deacetylase (HDAC) inhibitors. This comprehensive volume offers an in-depth review of the latest developments in HDAC inhibitors and their promising applications in cancer therapy. Ideal for researchers, clinicians, and students alike, this book serves as a vital resource for understanding the role of HDAC inhibitors in combinatorial anticancer strategies. Enhance your knowledge and stay at the forefront of oncological research with this essential addition to your library.